IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barre syndrome

Annals of Neurology

Volumn 44, Issue 2, 1998, Pages 202-208

  Kuwabara, Satoshi ^a   Yuki, Nobuhiro ^b   Koga, Michiaki ^b   Hattori, Takamichi ^a   Matsuura, Daisuke ^a   Miyake, Masami ^a   Noda, Masatoshi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; MALE; MOTOR NERVE; NERVE CONDUCTION; NERVE FIBER DEGENERATION; NERVE FIBER MEMBRANE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ADULT; AXONS; FEMALE; G(M1) GANGLIOSIDE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; NERVE DEGENERATION; NEURAL CONDUCTION; POLYRADICULONEUROPATHY;

EID: 0031859721     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410440210     Document Type: Article

References (30)

1. Feasby TE, Gilbert JJ, Brown WF, et al. An axonal form of Guillain-Barré polyneuropathy. Brain 1986;109:1115-1126
2. McKahnn GM, Cornblath DR, Griffin JW, et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 1993;33:333-342
3. Griffin JW, Li CY, Ho TW, et al. Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain 1995;118:577-595
4. Griffin JW, Li CY, Macko C, et al. Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome. J Neurocytol 1996;23:33-51
5. Hafer-Macko C, Hsieh S-T, Li CY, et al. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol 1996;40:635-644
6. Yuki N, Yoshino H, Sato S, Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobactet enteritis. Neurology 1990;40:1900-1902
7. Ho TW, Mishu B, Li CY, et al. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995;118:597-605
8. Kornberg AJ, Pestronk R, Bieser K, et al. The clinical correlates of high-titer IgG anti-GM1 antibodies. Ann Neurol 1994;35: 234-237
9. Visser LH, van der Méche FGA, van Doom PA, et al. Guillain-Barré syndrome without sensory loss (acute motor neuropathy). A subgroup with specific clinical, electrodiagnostic and laboratory features. Brain 1995;118:841-847
10. Rees JH, Gregson NA, Hughes RAC. Anti-GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobactor jejuni infection. Ann Neurol 1995;38:809-816
11. Enders U, Karch H, Toyka K, et al. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann Neurol 1993;34:136-144
12. Vriesendorp FJ, Triggs WJ, Mayer RF, Koski CL. Electrophysiological studies in Guillain-Barré syndrome: correlation with antibodies to GM1, GD1b and Campylobacter jejuni. J Neurol 1995;242:460-465
13. Ho TW, Hsieh ST, Nachamkin I, et al. Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection. Neurology 1997;48:717-724
14. Ho TW, Li CY, Cornblath DR, et al. Patterns of recovery in the Guillain-Barré syndromes. Neurology 1997;48:695-700
15. Waxman SG. Sodium channel blockade by antibodies: a new mechanism of neurological disease. Ann Neurol 1995;37:421-423
16. Triggs WJ, Cros D, Gominak SC, et al. Motor nerve inexcitability in Guillain-Barré syndrome. The spectrum of distal conduction block and axonal degeneration. Brain 1992;115:1291-1302
17. Baba M, Matsunaga M. Recovery from acute demyelinating conduction block in the presence of prolonged conduction delay due to peripheral nerve constriction. Electromyogr Clin Neurophysiol 1984;21:611-617
18. Clouston PDE, Kiers L, Zuniga G, Cros D. Quantitative analysis of the compound muscle action potential in early acute inflammatory demyelinating polyncuropathy. Electroencephalogr Clin Neurophysiol 1994;93:245-254
19. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990; 27(Suppl):S21-S24
20. Yuki N, Tagawa N, Irie F, et al. Close correlation of Guillain-Barré syndrome with antibodies to minor monosialogangliosides GM1b and GM1a. J Neuroimmunol 1997;74:30-34
21. Olney RK, Aminoff MJ. Electrodiagnostic features of the Guillain-Barré syndrome: the relative sensitivity of different techniques. Neurology 1990;40:471-475
22. Albers JW, Donofrio PD, McGonagle TK. Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 1985;8:528-529
23. Stys PK, Ransom BR, Waxman SG. Tertiary and quaternary local anesthetics protect CNS white matter from anoxic injury at concentrations that do not block excitability. J Neurophysiol 1992;67:236-240
24. Yokota T, Saito Y, Miyatake T. Conduction slowing without conduction block of compound muscle and nerve action potentials due to sodium channel block. J Neurol Sci 1994;124:220-224
25. Oda K, Araki K, Totoki T, Shibasaki H. Nerve conduction study of human tetrodotoxication. Neurology 1989;39:743-745
26. Long RR, Sargent JC, Hammer K. Paralytic shellfish poisoning: a case report and serial electrophysiologic observations. Neurology 1990;40:1310-1312
27. Santoro M, Uncini A, Corbo M, et al. Experimental conduction block induced by serum from a patient with anti-GM1 antibodies. Ann Neurol 1992;32:385-390
28. + currents in isolated rat myelinated nerve fibers. Ann Neurol 1995;37:436-442
29. Wirguin I, Rosoklija G, Trojaborg W, et al. Axonal degeneration accompanied by conduction block induced by toxin mediated immune reactivity to GM1 ganglioside in rat nerves. J Neurol Sci 1995;130:17-21
30. Sheikh KW, Deerinck TJ, Griffin JW, et al. Determination of the ultrastructural distribution of GM1 and asialo-GM1-like (Gal(b1-3)GalNAc) epitopes in peripheral nerve fibers. Neurology 1997;48:A281 (Abstract)